Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current drug metabolism

• Publication date

  2005-03-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389200053586091PMID 15853759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection

  2004cited by this paper
• Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone

  2004cited by this paper
• Coenzyme Q10 protects ischemic myocardium in an open-chest swine model

  2004cited by this paper
• Generation and Evaluation of a CYP2C9 Heteroactivation Pharmacophore

  2003cited by this paper
• In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin.

  2001cited by this paper
• Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics.

  1998cited by this paper
• Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.

  1998cited by this paper
• Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.

  1998cited by this paper
• Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.

  1998cited by this paper
• Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.

  1997cited by this paper
• The mechanisms of coenzyme Q10 as therapy for myocardial ischemia reperfusion injury.

  1997cited by this paper
• The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

  1997cited by this paper
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.

  1996cited by this paper
• Clinically Important Drug Interactions with Anticoagulants

  1996cited by this paper
• (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes.

  1996cited by this paper
• Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.

  1996cited by this paper
• Cytochrome P450.

  1995cited by this paper
• Treatment of warfarin-induced hair loss with ubidecarenone.

  1995cited by this paper
• Reduced effect of warfarin caused by ubidecarenone.

  1994cited by this paper
• An updating of the biochemical function of coenzyme Q in mitochondria.

  1994cited by this paper
• Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.

  1994cited by this paper
• Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.

  1993cited by this paper
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.

  1992cited by this paper
• Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.

  1992cited by this paper
• Plasma and tissue concentrations of coenzyme Q10 in the rat after intravenous, oral and topical administrations.

  1990cited by this paper
• Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

  1990cited by this paper
• Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.

  1989cited by this paper
• Stereochemistry of cytochrome P-450 reactions.

  1989cited by this paper
• Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

  1989cited by this paper
• The in vitro ketone reduction of warfarin and analogues. Substrate stereoselectivity, product stereoselectivity and species differences.

  1989cited by this paper
• Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.

  1986cited by this paper
• Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.

  1985cited by this paper
• Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin.

  1984cited by this paper
• High-yield synthesis of warfarin and its phenolic metabolites: new compounds.

  1983cited by this paper
• Stereochemical biotransformation of warfarin as a probe of the homogeneity and mechanism of microsomal hydroxylases.

  1977cited by this paper
• Warfarin-stereochemical aspects of its metabolism by rat liver microsomes.

  1976cited by this paper
• Warfarin: stereochemical aspects of its metabolism in vivo in the rat.

  1976cited by this paper
• Plasma half‐lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man *

  1973cited by this paper
• Kinetics of warfarin absorption in man

  1973cited by this paper
• The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.

  1972cited by this paper
• Influence of starvation on the metabolism of ubiquinone in the rat.

  1971cited by this paper
• Studies on the 4-hydroxycoumarins. Synthesis of the metabolites and some other derivatives of warfarin.

  1971cited by this paper
• Quinone interaction with the respiratory chain-linked NADH dehydrogenase of beef heart mitochondria.

  1970cited by this paper
• [Metabolism and effect of dimethyl sulfoxide].

  1968cited by this paper
• Oxidation-reduction status of coenzyme Q in rat liver microsomes.

  1965cited by this paper

• Therapeutic Effects of Coenzyme Q10 in the Treatment of Ischemic Stroke

  2024cites this paper
• Potential Drug–Nutrient Interactions of 45 Vitamins, Minerals, Trace Elements, and Associated Dietary Compounds with Acetylsalicylic Acid and Warfarin—A Review of the Literature

  2024cites this paper
• The Association between Food Groups, Nutraceuticals, and Food Supplements Consumption on Vascular Health Outcomes: A Literature Review

  2024cites this paper
• Beneficial antioxidant effects of Coenzyme Q10 on reproduction.

  2023cites this paper
• Amyotrophic Lateral Sclerosis: A Diet Review

  2021cites this paper
• Antagonists of Vitamin K—Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives

  2020cites this paper
• Effects of CYP2C11 gene knockout on the pharmacokinetics and pharmacodynamics of warfarin in rats

  2019cites this paper
• Chapter 25 – Heart Failure

  2018cites this paper
• Beyond weight loss after sleeve gastrectomy: improvement in health-related quality of life

  2018influential citation
• Coenzyme Q10 deficiency in elderly: Can nutritional supplementation play a role? Mini review

  2018cites this paper
• Integrated Approach to Heart Failure

  2017cites this paper
• Handbook Of Nutraceuticals: Volume I, Ingredients, Formulations And Applications

  2017cites this paper
• Coenzyme Q10 and Heart Failure: A State-of-the-Art Review

  2016cites this paper
• Commonly Used Dietary Supplements on Coagulation Function during Surgery

  2015influential citation
• Poisoning with Warfarin and Superwarfarin: What Can Laboratory Testing Do?

  2012cites this paper
• Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats

  2009cites this paper
• Nutraceuticals with Animal Origin

  2009cites this paper
• Capítulo 27 – Insuficiencia cardíaca

  2009cites this paper
• Ubiquinone and tocopherol: dissimilar siblings.

  2008cites this paper
• The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline

  2008cites this paper
• The uptake and distribution of coenzyme Q(10)

  2007cites this paper
• The uptake and distribution of coenzyme Q10.

  2007cites this paper
• Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

  2005cites this paper
• CoQ9 potentiates green tea antioxidant activities in Wistar rats

  2005cites this paper